AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. IVVD
  4. [Form 4] Invivyd, Inc. Insider Trading Activity

[Form 4] Invivyd, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Invivyd, Inc. (IVVD) Chief Financial Officer William E. Duke reported equity transactions tied to an RSU award granted Feb 15, 2025. The Form 4 shows 99,000 restricted stock units (RSUs) were granted (each convertible into one share) and vest over 18 months with one-third vesting every six months. On 08/15/2025 the Reporting Person was credited with 99,000 RSUs. Sell-to-cover transactions pursuant to a Rule 10b5-1 plan occurred on 08/18/2025 and 08/19/2025 to satisfy tax-withholding: 20,013 shares sold at a weighted average price of $0.6502 and 29,643 shares sold at a weighted average price of $0.5666. After these sales, the Reporting Person beneficially owned 78,987 shares and held 201,000 shares underlying outstanding RSUs and awards in total.

William E. Duke, Chief Financial Officer di Invivyd, Inc. (IVVD), ha comunicato operazioni su titoli relative a un premio in RSU concesso il 15/02/2025. Il Modulo 4 indica che sono state assegnate 99.000 unit脿 di azioni vincolate (RSU), ciascuna convertibile in una azione, che maturano nell'arco di 18 mesi con un terzo che matura ogni sei mesi. Il 15/08/2025 la persona che ha effettuato la comunicazione ha ricevuto accreditate 99.000 RSU. Per soddisfare le ritenute fiscali sono state eseguite operazioni di vendita "sell-to-cover" ai sensi di un piano Rule 10b5-1 il 18/08/2025 e il 19/08/2025: 20.013 azioni vendute a un prezzo medio ponderato di $0,6502 e 29.643 azioni vendute a un prezzo medio ponderato di $0,5666. Dopo queste vendite, la persona che ha effettuato la comunicazione deteneva la propriet脿 effettiva di 78.987 azioni e complessivamente 201.000 azioni sottostanti RSU e premi ancora in circolazione.

William E. Duke, director financiero de Invivyd, Inc. (IVVD), inform贸 transacciones de acciones relacionadas con una concesi贸n de RSU otorgada el 15/02/2025. El Formulario 4 muestra que se concedieron 99.000 unidades de acciones restringidas (RSU), cada una convertible en una acci贸n, que se devengan en 18 meses con un tercio que vence cada seis meses. El 15/08/2025, la persona informante recibi贸 acreditadas 99.000 RSU. Para cubrir las retenciones fiscales se realizaron ventas "sell-to-cover" conforme a un plan Rule 10b5-1 el 18/08/2025 y el 19/08/2025: 20.013 acciones vendidas a un precio medio ponderado de $0,6502 y 29.643 acciones vendidas a un precio medio ponderado de $0,5666. Tras estas ventas, la persona informante era beneficiaria de 78.987 acciones y pose铆a en total 201.000 acciones subyacentes a RSU y premios pendientes.

Invivyd, Inc.(IVVD)鞚� 斓滉碃鞛毂呾瀯鞛�(CFO) William E. Duke臧� 2025雲� 2鞗� 15鞚� 攵�鞐悳 RSU 氤挫儊瓿� 甏�霠悳 歆�攵勱卑霝橂ゼ 氤搓碃頄堨姷雼堧嫟. Form 4鞐愲姅 99,000臧滌潣 鞝滍暅攵� 欤检嫕雼渼(RSU)臧� 攵�鞐悩鞐堨溂氅�(臧� RSU電� 1欤茧 鞝勴櫂 臧�電�), 18臧滌洈鞐� 瓯胳硱 氩犾姢韺呺悩瓿� 6臧滌洈毵堧嫟 1/3鞌� 氩犾姢韸鸽悳雼り碃 旮办灛霅橃柎 鞛堨姷雼堧嫟. 2025-08-15鞐� 氤搓碃鞚胳潃 99,000 RSU毳� 瓿勳儊氚涭晿鞀惦媹雼�. 靹戈笀 鞗愳矞歆曥垬毳� 於╇嫻頃橁赴 鞙勴暣 Rule 10b5-1 瓿勴殟鞐� 霐半澕 2025-08-18瓿� 2025-08-19鞐� 'sell-to-cover' 瓯半灅臧� 鞁ろ枆霅橃棃瓿�, 20,013欤茧姅 臧�欷戫弶攴犼皜瓴� $0.6502鞐�, 29,643欤茧姅 臧�欷戫弶攴犼皜瓴� $0.5666鞐� 毵る弰霅橃棃鞀惦媹雼�. 鞚措摛 毵る弰 鞚错泟 氤搓碃鞚胳潃 鞁れ鞝侅溂搿� 78,987欤茧ゼ 氤挫湢頄堦碃, 齑� 201,000欤检潣 氙戈舶鞝� RSU 氚� 靾橃儊(awards)鞚� 旮办磮 欤检嫕鞚� 氤挫湢頃橁碃 鞛堨姷雼堧嫟.

William E. Duke, directeur financier d'Invivyd, Inc. (IVVD), a d茅clar茅 des op茅rations sur titres li茅es 脿 une attribution de RSU accord茅e le 15/02/2025. Le formulaire 4 indique que 99 000 unit茅s d'actions restreintes (RSU) ont 茅t茅 attribu茅es (chacune convertible en une action) et acqui猫rent des droits sur 18 mois, avec un tiers qui acquiert tous les six mois. Le 15/08/2025, la personne d茅clarante s'est vu cr茅diter 99 000 RSU. Pour couvrir les retenues fiscales, des op茅rations de vente "sell-to-cover" dans le cadre d'un plan Rule 10b5-1 ont eu lieu les 18/08/2025 et 19/08/2025 : 20 013 actions vendues 脿 un prix moyen pond茅r茅 de 0,6502 $ et 29 643 actions vendues 脿 un prix moyen pond茅r茅 de 0,5666 $. Apr猫s ces ventes, la personne d茅clarante d茅tenait effectivement 78 987 actions et disposait au total de 201 000 actions sous-jacentes aux RSU et autres attributions en circulation.

William E. Duke, Chief Financial Officer von Invivyd, Inc. (IVVD), meldete Aktiengesch盲fte im Zusammenhang mit einer am 15.02.2025 gew盲hrten RSU-Zuteilung. Das Formular 4 weist aus, dass 99.000 Restricted Stock Units (RSUs) gew盲hrt wurden (jeweils in eine Aktie umwandelbar), die 眉ber 18 Monate vesten, wobei ein Drittel alle sechs Monate f盲llig wird. Am 15.08.2025 wurden dem meldepflichtigen Personen 99.000 RSUs gutgeschrieben. Zur Begleichung der Steuerabz眉ge wurden im Rahmen eines Rule-10b5-1-Plans am 18.08.2025 und 19.08.2025 Sell-to-cover-Transaktionen durchgef眉hrt: 20.013 Aktien wurden zu einem gewichteten Durchschnittspreis von $0,6502 und 29.643 Aktien zu $0,5666 verkauft. Nach diesen Verk盲ufen hielt die meldende Person wirtschaftlich 78.987 Aktien und hielt insgesamt 201.000 Aktien, die RSUs und Awards zugrunde liegen.

Positive
  • Transparent disclosure of RSU grant terms and vesting schedule (18 months, one-third every six months).
  • Use of a Rule 10b5-1 plan and clear statement that sales were sell-to-cover for tax withholding, indicating procedural compliance.
  • Commitment to provide detailed pricing breakdowns for the multiple sales enhances transparency for regulators and shareholders.
Negative
  • Insider sold shares (49,656 total sold) which reduced direct beneficial ownership, though sales were for tax withholding.
  • Weighted-average sale prices disclosed are below $0.72, indicating sales executed at modest prices (ranges down to $0.5524).

Insights

TL;DR: Insider received RSUs and executed planned sell-to-cover sales under a 10b5-1 plan; transactions appear routine and not material to valuation.

The Form 4 discloses a non-discretionary sell-to-cover under a 10b5-1 plan adopted Feb 20, 2025, following RSU vesting. The sales covered tax withholding rather than discretionary cashing out; reported weighted-average prices and the mechanics are fully disclosed. The residual direct beneficial ownership post-sales is documented. No evidence in this filing of opportunistic insider timing or unusual transfers; impact on float is limited by the modest volumes relative to a public float (float not stated in this filing).

TL;DR: Disclosure aligns with standard governance practices for executive equity grants and tax-related share sales.

The RSU vesting schedule is explicitly stated (18 months, one-third every six months) and the use of a Rule 10b5-1 plan is disclosed on the Form 4, which supports compliance with insider trading policies. The reporting includes undertakings to provide per-price sale breakdowns to the company or SEC staff on request, enhancing transparency. No amendments or other governance red flags are present in the filing.

William E. Duke, Chief Financial Officer di Invivyd, Inc. (IVVD), ha comunicato operazioni su titoli relative a un premio in RSU concesso il 15/02/2025. Il Modulo 4 indica che sono state assegnate 99.000 unit脿 di azioni vincolate (RSU), ciascuna convertibile in una azione, che maturano nell'arco di 18 mesi con un terzo che matura ogni sei mesi. Il 15/08/2025 la persona che ha effettuato la comunicazione ha ricevuto accreditate 99.000 RSU. Per soddisfare le ritenute fiscali sono state eseguite operazioni di vendita "sell-to-cover" ai sensi di un piano Rule 10b5-1 il 18/08/2025 e il 19/08/2025: 20.013 azioni vendute a un prezzo medio ponderato di $0,6502 e 29.643 azioni vendute a un prezzo medio ponderato di $0,5666. Dopo queste vendite, la persona che ha effettuato la comunicazione deteneva la propriet脿 effettiva di 78.987 azioni e complessivamente 201.000 azioni sottostanti RSU e premi ancora in circolazione.

William E. Duke, director financiero de Invivyd, Inc. (IVVD), inform贸 transacciones de acciones relacionadas con una concesi贸n de RSU otorgada el 15/02/2025. El Formulario 4 muestra que se concedieron 99.000 unidades de acciones restringidas (RSU), cada una convertible en una acci贸n, que se devengan en 18 meses con un tercio que vence cada seis meses. El 15/08/2025, la persona informante recibi贸 acreditadas 99.000 RSU. Para cubrir las retenciones fiscales se realizaron ventas "sell-to-cover" conforme a un plan Rule 10b5-1 el 18/08/2025 y el 19/08/2025: 20.013 acciones vendidas a un precio medio ponderado de $0,6502 y 29.643 acciones vendidas a un precio medio ponderado de $0,5666. Tras estas ventas, la persona informante era beneficiaria de 78.987 acciones y pose铆a en total 201.000 acciones subyacentes a RSU y premios pendientes.

Invivyd, Inc.(IVVD)鞚� 斓滉碃鞛毂呾瀯鞛�(CFO) William E. Duke臧� 2025雲� 2鞗� 15鞚� 攵�鞐悳 RSU 氤挫儊瓿� 甏�霠悳 歆�攵勱卑霝橂ゼ 氤搓碃頄堨姷雼堧嫟. Form 4鞐愲姅 99,000臧滌潣 鞝滍暅攵� 欤检嫕雼渼(RSU)臧� 攵�鞐悩鞐堨溂氅�(臧� RSU電� 1欤茧 鞝勴櫂 臧�電�), 18臧滌洈鞐� 瓯胳硱 氩犾姢韺呺悩瓿� 6臧滌洈毵堧嫟 1/3鞌� 氩犾姢韸鸽悳雼り碃 旮办灛霅橃柎 鞛堨姷雼堧嫟. 2025-08-15鞐� 氤搓碃鞚胳潃 99,000 RSU毳� 瓿勳儊氚涭晿鞀惦媹雼�. 靹戈笀 鞗愳矞歆曥垬毳� 於╇嫻頃橁赴 鞙勴暣 Rule 10b5-1 瓿勴殟鞐� 霐半澕 2025-08-18瓿� 2025-08-19鞐� 'sell-to-cover' 瓯半灅臧� 鞁ろ枆霅橃棃瓿�, 20,013欤茧姅 臧�欷戫弶攴犼皜瓴� $0.6502鞐�, 29,643欤茧姅 臧�欷戫弶攴犼皜瓴� $0.5666鞐� 毵る弰霅橃棃鞀惦媹雼�. 鞚措摛 毵る弰 鞚错泟 氤搓碃鞚胳潃 鞁れ鞝侅溂搿� 78,987欤茧ゼ 氤挫湢頄堦碃, 齑� 201,000欤检潣 氙戈舶鞝� RSU 氚� 靾橃儊(awards)鞚� 旮办磮 欤检嫕鞚� 氤挫湢頃橁碃 鞛堨姷雼堧嫟.

William E. Duke, directeur financier d'Invivyd, Inc. (IVVD), a d茅clar茅 des op茅rations sur titres li茅es 脿 une attribution de RSU accord茅e le 15/02/2025. Le formulaire 4 indique que 99 000 unit茅s d'actions restreintes (RSU) ont 茅t茅 attribu茅es (chacune convertible en une action) et acqui猫rent des droits sur 18 mois, avec un tiers qui acquiert tous les six mois. Le 15/08/2025, la personne d茅clarante s'est vu cr茅diter 99 000 RSU. Pour couvrir les retenues fiscales, des op茅rations de vente "sell-to-cover" dans le cadre d'un plan Rule 10b5-1 ont eu lieu les 18/08/2025 et 19/08/2025 : 20 013 actions vendues 脿 un prix moyen pond茅r茅 de 0,6502 $ et 29 643 actions vendues 脿 un prix moyen pond茅r茅 de 0,5666 $. Apr猫s ces ventes, la personne d茅clarante d茅tenait effectivement 78 987 actions et disposait au total de 201 000 actions sous-jacentes aux RSU et autres attributions en circulation.

William E. Duke, Chief Financial Officer von Invivyd, Inc. (IVVD), meldete Aktiengesch盲fte im Zusammenhang mit einer am 15.02.2025 gew盲hrten RSU-Zuteilung. Das Formular 4 weist aus, dass 99.000 Restricted Stock Units (RSUs) gew盲hrt wurden (jeweils in eine Aktie umwandelbar), die 眉ber 18 Monate vesten, wobei ein Drittel alle sechs Monate f盲llig wird. Am 15.08.2025 wurden dem meldepflichtigen Personen 99.000 RSUs gutgeschrieben. Zur Begleichung der Steuerabz眉ge wurden im Rahmen eines Rule-10b5-1-Plans am 18.08.2025 und 19.08.2025 Sell-to-cover-Transaktionen durchgef眉hrt: 20.013 Aktien wurden zu einem gewichteten Durchschnittspreis von $0,6502 und 29.643 Aktien zu $0,5666 verkauft. Nach diesen Verk盲ufen hielt die meldende Person wirtschaftlich 78.987 Aktien und hielt insgesamt 201.000 Aktien, die RSUs und Awards zugrunde liegen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Duke William E.
(Last) (First) (Middle)
C/O INVIVYD, INC.
1601 TRAPELO ROAD, SUITE 178
(Street)
WALTHAM MA 02451
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Invivyd, Inc. [ IVVD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/15/2025 M 99,000 A (1) 99,000 D
Common Stock 08/18/2025 S 20,013(2) D $0.6502(3) 78,987 D
Common Stock 08/19/2025 S 29,643(2) D $0.5666(4) 49,344 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 08/15/2025 M 99,000 (5) (5) Common Stock 99,000 $0.00 201,000 D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
2. The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.
3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5801 to $0.7134, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.5524 to $0.6040, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
5. This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
Remarks:
Exhibit 24.1: Power of Attorney
/s/ Jill Andersen attorney-in-fact for William E. Duke 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What transactions did Invivyd (IVVD) CFO William E. Duke report on Form 4?

The Form 4 reports a grant of 99,000 RSUs and subsequent sell-to-cover sales of 20,013 and 29,643 shares on 08/18/2025 and 08/19/2025, respectively.

Why were shares sold by the reporting person on 08/18/2025 and 08/19/2025?

The sales were sell-to-cover transactions to satisfy tax-withholding obligations upon vesting of RSUs, executed pursuant to a Rule 10b5-1 plan.

How many shares does William E. Duke beneficially own after the reported transactions?

After the reported sales the filing shows 78,987 shares beneficially owned directly and a total of 201,000 shares underlying RSUs/awards reported as outstanding following the transactions.

What were the sale prices for the shares sold?

The Form 4 reports weighted-average prices: $0.6502 for the 20,013 shares and $0.5666 for the 29,643 shares; individual sale prices ranged from $0.5524 to $0.7134 depending on the transactions.

When was the Rule 10b5-1 plan adopted by the reporting person?

The Form 4 states the reporting person adopted the Rule 10b5-1 plan on February 20, 2025.
Stock IVVD logo
Invivyd

NASDAQ:IVVD

IVVD Rankings

#5006 Ranked by Market Cap
N/A Ranked by Dividends
#1 Top Loser

IVVD Latest News

Aug 20, 2025
Invivyd Announces Pricing of $50 Million Public Offering of Common Stock and Pre-Funded Warrants
Aug 20, 2025
Invivyd Announces Proposed Public Offering of Common Stock
Aug 18, 2025
Invivyd Announces Continued Neutralizing Activity of PEMGARDA庐 (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (鈥淪tratus鈥�)
Aug 14, 2025
Invivyd Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Aug 14, 2025
Invivyd Aligns with U.S. FDA on Rapid Pathway to Full Approval (BLA) of Vaccine Alternative Monoclonal Antibody VYD2311 to Protect American Adults and Adolescents from COVID-19

IVVD Latest SEC Filings

Aug 20, 2025
[424B5] Invivyd, Inc. Prospectus Supplement (Debt Securities)
Aug 19, 2025
[Form 4] Invivyd, Inc. Insider Trading Activity
Aug 19, 2025
[Form 4] Invivyd, Inc. Insider Trading Activity
Aug 19, 2025
[Form 4] Invivyd, Inc. Insider Trading Activity
Aug 19, 2025
[Form 4] Invivyd, Inc. Insider Trading Activity

IVVD Stock Data

69.71M
69.63M
41.12%
57.5%
2.77%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
WALTHAM